ProPhase Labs, Inc. (PRPH)
NASDAQ: PRPH · Real-Time Price · USD
0.626
-0.017 (-2.61%)
At close: Dec 26, 2024, 4:00 PM
0.650
+0.024 (3.82%)
After-hours: Dec 26, 2024, 7:45 PM EST
ProPhase Labs Employees
ProPhase Labs had 113 employees as of December 31, 2023. The number of employees decreased by 16 or -12.40% compared to the previous year.
Employees
113
Change (1Y)
-16
Growth (1Y)
-12.40%
Revenue / Employee
$112,858
Profits / Employee
-$245,628
Market Cap
14.95M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Marinus Pharmaceuticals | 166 |
bioAffinity Technologies | 75 |
Aptose Biosciences | 36 |
GlycoMimetics | 35 |
Nephros | 31 |
MEI Pharma | 28 |
Minerva Neurosciences | 9 |
Acurx Pharmaceuticals | 4 |
PRPH News
- 5 weeks ago - ProPhase Labs, Inc. (PRPH) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - ProPhase Labs Inc. to Present Third Quarter 2024 Financial Results on November 13, 2024 - GlobeNewsWire
- 6 weeks ago - ProPhase Labs Announces Pricing of Public Offering of Common Stock - GlobeNewsWire
- 2 months ago - ProPhase Labs Announces Positive Updates on Strategic Initiatives Company Anticipates Multiple Liquidity Events in H1 2025 - GlobeNewsWire
- 4 months ago - Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH) - GlobeNewsWire
- 4 months ago - ProPhase Labs to Present at August 20th Virtual Investor Summit Microcap Event - GlobeNewsWire
- 4 months ago - ProPhase Labs, Inc. (PRPH) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - PROPHASE LABS INC. TO PRESENT SECOND QUARTER 2024 FINANCIAL RESULTS ON AUGUST 14 - GlobeNewsWire